jain.com

Convertible noteholder treatment under restructuring plan

Company: Core Scientific

Subject kind
financing
Statement date
2023-10-29
Promised amount
670000000.0 USD
Current status
stated

The claim, verbatim

Under the restructuring term sheet, convertible noteholders are to receive $150 million in New Secured Notes, $260 million in New Secured Convertible Notes, and $260 million in equity, plus contingent payment obligations of up to $130 million.

Source (primary)

core-scientific 8-K exhibit (d524676dex992.htm) (SEC EDGAR (8-K Ex), press_release)
View cached copy (2026-11-18)Live source ↗

Quote: “$150 million in New Secured Notes - $260 million in New Secured Convertible Notes - $260 million in Equity”

How we checked this

Checked on November 20, 2026. The cited source supports every part of this claim.

The term sheet lists this treatment for the April and August convertible notes: $150 million in New Secured Notes, $260 million in New Secured Convertible Notes, $260 million in equity, and contingent payment obligations of up to $130 million.

Confirmed in the source:

What we did: Read our cached copy of SEC EDGAR (8-K Ex) (https://www.sec.gov/Archives/edgar/data/1839341/000119312523266221/d524676dex992.htm) in full (18,293 characters, retrieved November 18, 2026) and checked each assertion in the claim against it.

Additional evidence

confirms core-scientific 8-K exhibit (d524676dex992.htm)

Quote: “$150 million in New Secured Notes - $260 million in New Secured Convertible Notes - $260 million in Equity”

View cached copy (2026-11-18)Live source ↗